Showing results (21-30 of 228) with videos related to

Sort By:
Pageof 23
Clinical Genetics|May 3, 2006
High prevalence of the IVS 1 + 1 G to A/GJB2 mutation among Czech hearing impaired patients with monoallelic mutation in the coding region of GJB2P Seeman, I Sakmaryová
Canadian Journal of Physiology and Pharmacology|March 1, 1982
Effects of antihypertensive clonidine congeners on alpha-adrenergic receptorsM Titeler, P Seeman
European Journal of Pharmacology|October 17, 1980
Presynaptically acting catecholamines bind to alpha 2-adrenoceptors labelled by 3H-clonidineM Titeler, P Seeman
Experientia|November 15, 1978
Antiparkinsonian drug doses and neuroleptic receptorsM Titeler, P Seeman
Molecular Psychiatry|May 13, 1998
Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptorsP Seeman, T Tallerico
The American Journal of Psychiatry|June 9, 1999
Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapineP Seeman, T Tallerico
Science (New York, N.Y.)|June 20, 1975
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neuronsP Seeman, T Lee
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1978
Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptorsM Titeler, P Seeman
Drug and Alcohol Dependence|January 1, 1979
Mechanisms of ethanol tolerance at a cholinergic nerve terminalM Curran, P Seeman
The American Journal of Psychiatry|March 7, 2001
Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesisS Kapur, P Seeman
Pageof 23